UK Continuous Renal Replacement Therapy Market To Reach $131.69 Million By 2030

UK Continuous Renal Replacement Therapy Market Growth & Trends

The UK continuous renal replacement therapy market size is anticipated to reach USD 131.7 million by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by numerous factors such as technological advancements such as innovations in design, materials, and manufacturing processes. These advancements have improved the safety, efficiency, and efficacy of CRRT treatments.

One of the most significant advancements in CRRT technology is the development of faster and more efficient filtration systems. New membrane technologies, such as hollow-fiber membranes and nanofiltration, have increased filtration rates and reduced treatment time. This means that patients can receive more effective treatment while minimizing the risk of complications like hemolysis and bleeding. Further, new tubing materials, such as heparin-coated lines, have minimized blood trauma and reduced the risk of complications like hemolysis. This is particularly important in patients with compromised blood vessels or those who are at risk of bleeding.

Moreover, key manufacturers in the industry are prioritizing the development and implementation of digital technologies to enhance knowledge of CRRT among healthcare professionals. For instance, in March 2024 Fresenius Medical Care recently launched an innovative Augmented Reality (AR) application. This cutting-edge technology enables nursing staff to learn Kidney Replacement Therapy in Intensive Care Units more effectively. The AR glasses, paired with digital learning modules, allow nursing staff to gain hands-on experience with acute dialysis machines directly within the intensive care wards. As users interact with the machines, the glasses stream visual and acoustic recordings, providing a comprehensive and immersive learning experience for healthcare professionals.

 Request a free sample copy or view report summary: UK Continuous Renal Replacement Therapy Market Report

UK Continuous Renal Replacement Therapy Market Report Highlights

• The consumables segment dominated the market and accounted for a revenue share of 60.40% in 2023. On the other hand, the consumables segment is expected to register the fastest CAGR during the forecast period owing to growing demand for continuous renal replacement therapy (CRRT) and rising awareness of CRRT benefits.

• The Continuous Venovenous Hemofiltration (CVVH) segment dominated the market and is also expected to register the fastest CAGR of 10.2% during the forecast period. Manufacturers are providing clinical education and training to healthcare professionals on the use of CVVH technology, which is helping to increase adoption and utilization.

• England segment dominated the market in 2023 owing to growing cases of AKI. For instance, according to The Renal Association report published in 2023, in 2022, the rate of AKI episodes per million population was 12,651, compared to 11,660 in 2018.

• Baxter, B. Braun Medical Ltd, Medtronic, Fresenius Medical Care UK Ltd, Braun & Co. Limited, Medica Advanced Technologies Ltd, and NIKKISO UK Co. Ltd. are the key players in the UK Continuous Renal Replacement Therapy (CRRT) market.

UK Continuous Renal Replacement Therapy Market Segmentation

Grand View Research has segmented the UK continuous renal replacement therapy market on the basis of product, modality, and region:

Continuous Renal Replacement Therapy (CRRT) Product Outlook (Revenue, USD Million; 2018 - 2030)

• Consumables

• Systems

Continuous Renal Replacement Therapy (CRRT) Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Continuous venovenous hemofiltration (CVVH)

• Continuous venovenous hemodiafiltration (CVVHDF)

• Continuous venovenous hemodialysis (CVVHD)

• Slow continuous ultra filtration (SCUF)

Continuous Renal Replacement Therapy (CRRT) Region Outlook (Revenue, USD Million; 2018 - 2030)

• UK

  • England

  • Scotland

  • Wales

  • Northern Ireland

List of Key Players in UK Continuous Renal Replacement Therapy Market

• Baxter

• B. Braun Medical Ltd

• Medtronic

• Fresenius Medical Care UK Ltd

• Braun & Co. Limited

• Medica Advanced Technologies Ltd

• NIKKISO UK Co. Ltd.